1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Neurosurgical Products Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Neurosurgical Products Market, North America
3.1 Neurosurgical Products Market, North America, Revenue ($m), 2018-2033
3.2 Neurosurgical Products Market, North America, Revenue ($m), 2018-2033
3.3 Neurosurgical Products Market, North America, Volume (Units), 2018-2033
3.4 Neurosurgical Products Market, North America, Volume (Units), 2018-2033
3.5 Neurosurgical Products Market, North America, Company Share by Revenue ($m), 2025
4 Neurosurgical Products Market, Canada
4.1 Neurosurgical Products Market, Canada, Revenue ($m), 2018-2033
4.1.1 Dura Substitutes Market, Canada, Revenue ($m), by Segment, 2018-2033
4.1.2 Neuroendoscopes Market, Canada, Revenue ($m), by Segment, 2018-2033
4.1.3 Neurosurgical Drills Market, Canada, Revenue ($m), by Segment, 2018-2033
4.2 Neurosurgical Products Market, Canada, Volume (Units), 2018-2033
4.2.1 Dura Substitutes Market, Canada, Volume (Units), by Segment, 2018-2033
4.2.2 Neuroendoscopes Market, Canada, Volume (Units), by Segment, 2018-2033
4.2.3 Neurosurgical Drills Market, Canada, Volume (Units), by Segment, 2018-2033
4.3 Neurosurgical Products Market, Canada, Average Price ($), 2018-2033
4.4 Neurosurgical Products Market, Canada, Company Share by Revenue ($m), 2025
5 Neurosurgical Products Market, Mexico
5.1 Neurosurgical Products Market, Mexico, Revenue ($m), 2018-2033
5.1.1 Dura Substitutes Market, Mexico, Revenue ($m), by Segment, 2018-2033
5.1.2 Neuroendoscopes Market, Mexico, Revenue ($m), by Segment, 2018-2033
5.1.3 Neurosurgical Drills Market, Mexico, Revenue ($m), by Segment, 2018-2033
5.2 Neurosurgical Products Market, Mexico, Volume (Units), 2018-2033
5.2.1 Dura Substitutes Market, Mexico, Volume (Units), by Segment, 2018-2033
5.2.2 Neuroendoscopes Market, Mexico, Volume (Units), by Segment, 2018-2033
5.2.3 Neurosurgical Drills Market, Mexico, Volume (Units), by Segment, 2018-2033
5.3 Neurosurgical Products Market, Mexico, Average Price ($), 2018-2033
5.4 Neurosurgical Products Market, Mexico, Company Share by Revenue ($m), 2025
6 Neurosurgical Products Market, United States
6.1 Neurosurgical Products Market, United States, Revenue ($m), 2018-2033
6.1.1 Dura Substitutes Market, United States, Revenue ($m), by Segment, 2018-2033
6.1.2 Neuroendoscopes Market, United States, Revenue ($m), by Segment, 2018-2033
6.1.3 Neurosurgical Drills Market, United States, Revenue ($m), by Segment, 2018-2033
6.2 Neurosurgical Products Market, United States, Volume (Units), 2018-2033
6.2.1 Dura Substitutes Market, United States, Volume (Units), by Segment, 2018-2033
6.2.2 Neuroendoscopes Market, United States, Volume (Units), by Segment, 2018-2033
6.2.3 Neurosurgical Drills Market, United States, Volume (Units), by Segment, 2018-2033
6.3 Neurosurgical Products Market, United States, Average Price ($), 2018-2033
6.4 Neurosurgical Products Market, United States, Company Share by Revenue ($m), 2025
7 Overview of Key Companies in North America Neurosurgical Products Market
7.1 Integra LifeSciences Corp
7.1.1 Company Overview
7.2 B. Braun Melsungen AG
7.2.1 Company Overview
7.3 Medtronic Plc
7.3.1 Company Overview
7.4 KARL STORZ SE & Co KG
7.4.1 Company Overview
7.5 Stryker Corp
7.5.1 Company Overview
7.6 DePuy Synthes Inc
7.6.1 Company Overview
7.7 Baxter International Inc
7.7.1 Company Overview
7.8 Clearmind Biomedical Inc
7.8.1 Company Overview
7.9 Regenity Biosciences
7.9.1 Company Overview
7.10 Adeor Medical AG
7.10.1 Company Overview
8 Neurosurgical Products Market Pipeline Products
9 Recent Developments
9.1 Corporate Communications
9.1.1 Nov 17, 2025: MicroTransponder Appoints Dana G. Mead, Jr. as Chair and Cynthia Lucchese as Independent Director
9.1.2 Nov 13, 2025: UMSON Appoints New Co-Directors for Center for Health Equity and Outcomes Research
9.1.3 Nov 04, 2025: BrainScope Appoints Matt Adams as Chief Executive Officer
9.1.4 Oct 31, 2025: University of Maryland School of Medicine Researchers Discover Biomarker Evidence Linking Prurigo Nodularis to Kidney Disease
9.1.5 Oct 30, 2025: Siddiqui Performs World’s First Robotic Microsurgical Intracranial Brain Surgery
9.1.6 Sep 16, 2025: Investment in Neurotechnology Innovation
9.1.7 Sep 08, 2025: Stefan Kappe, PhD, Named Director of UM Center for Vaccine Development and Global Health
9.1.8 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed
9.1.9 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio
9.1.10 Mar 13, 2025: MicroTransponder receives $65m to advance stroke care with Vivistim
9.2 Financial Announcements
9.2.1 Oct 01, 2025: Organogenesis Holdings Inc. To Report Third Quarter Financial Results
9.2.2 Aug 07, 2025: Organogenesis Holdings Reports Second Quarter 2025 Financial Results
9.2.3 Jul 29, 2025: NeuroPace to Report Second Quarter 2025 Financial Results on August 12, 2025
9.2.4 Jul 22, 2025: Organogenesis Holdings to Report Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025
9.2.5 May 05, 2025: Integra LifeSciences Reports First Quarter 2025 Financial Results
9.2.6 Apr 18, 2025: Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025
9.3 Government and Public Interest
9.3.1 Dec 01, 2025: Integra LifeSciences Leadership to Present at Citi 2025 Global Healthcare Conference
9.3.2 Aug 29, 2025: Integra LifeSciences Leadership to Present at Wells Fargo and Morgan Stanley Healthcare Investor Conferences
9.3.3 Aug 27, 2025: Organogenesis Holdings to Participate in Upcoming Investor Conferences in September
9.3.4 Mar 26, 2025: NeuroPace to Present at the 24th Annual Needham Virtual Healthcare Conference
9.3.5 Mar 03, 2025: NeuroPace to Present at the Leerink Partners Global Healthcare Conference
9.4 Product News
9.4.1 Nov 10, 2025: URI Team Develops Tabletop Device to Study Long-Term Effects of Traumatic Brain Injury
9.4.2 Nov 05, 2025: MMI Receives IDE Approval from FDA for First Robotic Microsurgical Study in Alzheimer’s Patients
9.4.3 Oct 30, 2025: Siddiqui Performs World’s First Robotic Microsurgical Intracranial Brain Surgery
9.4.4 Oct 14, 2025: NeuroOne Expands Patent Portfolio With Recent USPTO and EPO Decisions
9.4.5 Oct 08, 2025: Integra Lifesciences to Showcase Neurosurgical Products at CNS Annual Meeting
9.4.6 Oct 06, 2025: MMI Achieves Breakthrough In Robotic Microsurgical Intracranial Brain Surgery
9.4.7 Sep 23, 2025: FDA Clears Cionic Neural Sleeve 2 For Enhanced Mobility Care
9.5 Strategy And Business Planning
9.5.1 Feb 20, 2025: MellingMedical Welcomes Black Forest Medical Group to Its Select Portfolio of Medical Products Providers
10 Appendix
10.1 Research Methodology
10.1.1 Coverage
10.1.2 Secondary Research
10.1.3 Primary Research
10.1.4 Market Modeling and Forecasting
10.1.5 Company Share Analysis
10.1.6 Benchmarking
10.2 GlobalData Consulting
10.3 Contact Us
10.4 Disclaimer